Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Metaphit: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{chembox}} taken from revid 461617591 of page Metaphit for the Chem/Drugbox validation project (updated: 'ChEMBL'). |
No edit summary |
||
Line 1: | Line 1: | ||
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid [{{fullurl:Metaphit|oldid=461617591}} 461617591] of page [[Metaphit]] with values updated to verified values.}} |
|||
{{Chembox |
{{Chembox |
||
| verifiedrevid = |
| verifiedrevid = 461743085 |
||
| ImageFile = |
| ImageFile = Metaphit.svg |
||
| ImageSize = |
| ImageSize = |
||
| |
| PIN = 1-[1-(3-Isothiocyanatophenyl)cyclohexyl]piperidine |
||
| OtherNames = |
| OtherNames = |
||
| |
|Section1={{Chembox Identifiers |
||
| |
| CASNo_Ref = {{cascite|correct|??}} |
||
| CASNo = |
| CASNo = 96316-00-6 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
⚫ | |||
| UNII = NFS3HJC8WD |
|||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
|||
⚫ | |||
| PubChem = 114745 |
| PubChem = 114745 |
||
| |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 102730 |
| ChemSpiderID = 102730 |
||
| |
| SMILES = S=C=N\c1cccc(c1)C3(N2CCCCC2)CCCCC3 |
||
| |
| InChI = 1/C18H24N2S/c21-15-19-17-9-7-8-16(14-17)18(10-3-1-4-11-18)20-12-5-2-6-13-20/h7-9,14H,1-6,10-13H2 |
||
| |
| InChIKey = FGSGBQAQSPSRJK-UHFFFAOYAE |
||
| |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C18H24N2S/c21-15-19-17-9-7-8-16(14-17)18(10-3-1-4-11-18)20-12-5-2-6-13-20/h7-9,14H,1-6,10-13H2 |
| StdInChI = 1S/C18H24N2S/c21-15-19-17-9-7-8-16(14-17)18(10-3-1-4-11-18)20-12-5-2-6-13-20/h7-9,14H,1-6,10-13H2 |
||
| |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = FGSGBQAQSPSRJK-UHFFFAOYSA-N |
| StdInChIKey = FGSGBQAQSPSRJK-UHFFFAOYSA-N |
||
}} |
}} |
||
| |
|Section2={{Chembox Properties |
||
| |
| Formula = C<sub>18</sub>H<sub>24</sub>N<sub>2</sub>S |
||
| |
| MolarMass = 300.462 |
||
| |
| Appearance = |
||
| |
| Density = |
||
| |
| MeltingPt = |
||
| |
| BoilingPt = |
||
| |
| Solubility = |
||
}} |
}} |
||
| |
|Section3={{Chembox Hazards |
||
| |
| MainHazards = |
||
| |
| FlashPt = |
||
| |
| AutoignitionPt = |
||
}} |
}} |
||
}} |
}} |
||
[[Image:Metaphit methanesulfonate.png|right|thumb|250 px|Metaphit as a [[methanesulfonate]] salt]] |
|||
'''Metaphit''' ('''1-[1-(3-Isothiocyanato)phenyl]cyclohexylpiperidine''') is a research chemical that acts as an acylator of [[NMDA receptor antagonist|NMDARAn]], [[Sigma receptor|sigma]] and [[Dopamine transporter|DAT]] binding sites in the [[Central nervous system|CNS]]. It is the ''m''-isothiocyanate derivative of [[phencyclidine]] (PCP) and binds irreversibly (forming a [[covalent bond]]) to the PCP binding site on the NMDA receptor complex.<ref>{{cite journal |pages=318–22 |doi=10.1016/0014-5793(85)80284-2 |title=A specific acylating agent for the [<sup>3</sup>H]phencyclidine receptors in rat brain |year=1985 |last1=Rafferty |first1=Michael F. |last2=Mattson |first2=Mariena |last3=Jacobson |first3=Arthur E. |last4=Rice |first4=Kenner C. |journal=FEBS Letters |volume=181 |issue=2 |pmid=2982662|doi-access=free }}</ref> However, later studies suggest the functionality of metaphit is mediated by sites not involved in PCP-induced passive avoidance deficit, and not related to the NMDA receptor complex.<ref>{{cite journal |pages=231–3 |doi=10.1016/0091-3057(91)90618-C |title=Metaphit fails to antagonize PCP-induced passive avoidance deficit |year=1991 |last1=Danysz |first1=Wojciech |journal=Pharmacology Biochemistry and Behavior |volume=38 |pmid=1826788 |issue=1}}</ref> Metaphit was also shown to prevent d-amphetamine induced hyperactivity, while significantly depleting dopamine content in the nucleus accumbens.<ref>{{cite journal |pages=267–74 |doi=10.1016/0014-2999(87)90283-4 |title=Metaphit, a proposed phencyclidine (PCP) antagonist, prevents PCP-induced locomotor behavior through mechanisms unrelated to specific blockade of PCP receptors |year=1987 |last1=French |first1=Edward D. |last2=Jacobson |first2=Arthur E. |last3=Rice |first3=Kenner C. |journal=European Journal of Pharmacology |volume=140 |issue=3 |pmid=2820762}}</ref> Metaphit was the first acylating ligand used to study the [[cocaine]] receptor.<ref>{{cite journal |first1=F. Ivy |last1=Carroll |first2=Anita H. |last2=Lewin |first3=John W. |last3=Boja |first4=Michael J. |last4=Kuharf |pages=969–81 |doi=10.1021/jm00084a001 |title=Cocaine receptor: Biochemical characterization and structure-activity relationships of cocaine analogs at the dopamine transporter |year=1992 |journal=Journal of Medicinal Chemistry |volume=35 |issue=6 |pmid=1552510}}</ref> It is a structural isomer of the similar research compound [[fourphit]], as it and metaphit both are isothiocyanate substituted derivatives of an analogous scaffold shared with PCP.<ref>{{cite journal | pmid = 1602399 | volume=261 | title=Fourphit: a selective probe for the methylphenidate binding site on the dopamine transporter | journal=J Pharmacol Exp Ther | pages=936-42 | last1 = Schweri | first1 = MM | last2 = Thurkauf | first2 = A | last3 = Mattson | first3 = MV | last4 = Rice | first4 = KC}}</ref> |
|||
==References== |
|||
{{Reflist|2}} |
|||
{{Navboxes |
|||
| title = [[Pharmacodynamics]] |
|||
| titlestyle = background:#ccccff |
|||
| list1 = |
|||
{{Monoamine reuptake inhibitors}} |
|||
{{Ionotropic glutamate receptor modulators}} |
|||
{{Sigma receptor modulators}} |
|||
}} |
|||
[[Category:Arylcyclohexylamines]] |
|||
[[Category:Dopamine reuptake inhibitors]] |
|||
[[Category:Dissociative drugs]] |
|||
[[Category:NMDA receptor antagonists]] |
|||
[[Category:1-Piperidinyl compounds]] |
|||
[[Category:Sigma agonists]] |
|||
[[Category:Irreversible antagonists]] |
|||
[[Category:Irreversible agonists]] |
|||
[[Category:Isothiocyanates]] |
|||
{{Pharma-stub}} |